CJC-1295 + Ipamorelin
the GH secretagogue pair
The most commonly paired growth-hormone secretagogues, in an even split.
What it is
CJC-1295 + Ipamorelin is the classic growth-hormone-secretagogue blend. It pairs a GHRH analog with a selective secretagogue because the two act on different pathways.
This page describes each component and why the pairing is discussed, from the profile data. It is not a dosing schedule.
Composition
What's in a typical CJC-1295 + Ipamorelin blend
The percentages show the ratio used on this page. The milligram amounts show the 20mg example.
Sold by vendors in 10mg, 20mg.
Blend calculator
Calculate from the vial you actually have
Blend formulas and vial sizes vary. Enter each component amount from your label, then add the BAC-water volume and the target amount from your instructions. The calculator uses those values, not the example formula above.
Your vial
Use the exact amounts printed on your vial. The listed formula is only a starting point.
Total-only mode assumes your vial matches the listed ratio. If your label gives component amounts, use exact entry.
Only calculate from total mass when the label confirms this ratio.
Draw
1.5 U-100 units
0.015 mL · 0.2 mg total blend
This draw is below 5 U-100 units and may be too small to measure reliably. Recheck the vial, water, target amount, and unit against your instructions.
- CJC-1295 (no DAC)0.1 mg
- Ipamorelin0.1 mg
U-100 math assumes 100 syringe units per mL. Confirm the vial formula, diluent, and target amount against the product label and your licensed professional's instructions.
Dosing context
How CJC-1295 + Ipamorelin is typically dosed
A common approach is around 0.1 mg of each component per dose.
Schedule. Once at night, fasted, commonly daily. Commonly discussed in cycles of around 8 weeks.
A pre-mixed 50/50 vial delivers equal amounts, so a common approach is about 0.1 mg (100 mcg) of each per evening dose. Note that when the two are run from separate vials, a 1 part CJC-1295 to 2 parts Ipamorelin split is also common.
Why these components
Why they're grouped together
- CJC-1295 (no DAC). A growth-hormone-releasing-hormone analog — half of the even split.
- Ipamorelin. A selective growth-hormone secretagogue acting on a different pathway, which is why the two are commonly paired.
Who it's for
This blend is a common research topic for people reading the growth-hormone-secretagogue literature.
Where it's sold
Live vendor pricing
All pricing →Safety context
- Each peptide has its own timing and safety profile; pairing them does not average those away.
- Growth-hormone-axis compounds are typically discussed alongside professional supervision.
- Verify COAs and third-party testing per product.
Questions people ask
Why are CJC-1295 and Ipamorelin used together?
They act through complementary pathways — one is a GHRH analog, the other a selective secretagogue — which is why they are the most commonly paired GH secretagogues in research discussion. This page is educational and not a recommendation to combine them.
Is CJC-1295 + Ipamorelin safe?
CJC-1295 + Ipamorelin combines research compounds (CJC-1295 (no DAC), Ipamorelin), each with its own safety profile that blending does not average away. This page is educational context, not medical advice, and does not tell you to start, stop, or combine anything. Whether any blend is appropriate is a decision for a licensed professional.
How is CJC-1295 + Ipamorelin typically dosed?
CJC-1295 + Ipamorelin is a fixed-ratio blend, so guidance usually describes a consistent 0.1 mg of each component per dose, with the other components delivered in proportion. Once at night, fasted, commonly daily. This is educational context and not a dose recommendation or medical advice.
This page is for research and educational purposes only. It is not medical advice and does not diagnose, treat, prescribe, or tell you to start, stop, or combine any protocol. A licensed professional is the right person to evaluate any combination.
Other blends